Beigene (ONC) Financials

$241.43 +2.67 (+1.12%)

As of 04:00 PM Eastern

Annual Income Statements for Beigene

This table shows Beigene's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	-645	-882	-2,004	-1,458	-1,625	-949	-674	-93	-119	-57
Consolidated Net Income / (Loss)	-645	-882	-2,004	-1,458	-1,629	-951	-674	-93	-119	-57
Net Income / (Loss) Continuing Operations	-645	-882	-2,004	-1,458	-1,629	-951	-674	-93	-119	-57
Total Pre-Tax Income	-533	-826	-1,961	-1,439	-1,618	-944	-690	-91	-119	-57
Total Operating Income	-568	-1,208	-1,790	-1,439	-1,658	-960	-706	-98	-117	-57
Total Gross Profit	3,216	2,079	1,129	1,011	238	357	170	233	1.07	8.82
Total Revenue	3,810	2,459	1,416	1,176	309	428	198	238	1.07	8.82
Operating Revenue	3,810	2,459	1,416	1,176	309	428	198	238	1.07	8.82
Total Cost of Revenue	594	380	286	165	71	71	29	4.97	0.00	0.00
Operating Cost of Revenue	594	380	286	165	71	71	29	4.97	0.00	0.00
Total Operating Expenses	3,784	3,287	2,919	2,450	1,896	1,317	875	332	118	66
Selling, General & Admin Expense	1,831	1,508	1,279	990	600	388	195	63	20	7.31
Research & Development Expense	1,953	1,779	1,641	1,459	1,295	927	679	269	98	58
Total Other Income / (Expense), net	35	382	-171	0.15	39	16	16	7.39	-2.10	-0.36
Interest & Investment Income	48	74	52	-	-	-	-	-	-	-
Other Income / (Expense), net	-13	308	-224	16	37	7.17	1.99	12	-2.49	-0.92
Income Tax Expense	112	56	43	19	10	6.99	-16	2.24	0.05	0.00
Basic Earnings per Share	($0.47)	($0.65)	($1.49)	($1.21)	($1.50)	($1.22)	($0.93)	($0.17)	($0.30)	($0.52)
Weighted Average Basic Shares Outstanding	1.37B	1.36B	1.34B	1.21B	1.09B	780.70M	55.44M	543.19M	31.05M	110.60M
Diluted Earnings per Share	($0.47)	($0.65)	($1.49)	($1.21)	($1.50)	($1.22)	($0.93)	($0.17)	($0.30)	($0.52)
Weighted Average Diluted Shares Outstanding	1.37B	1.36B	1.34B	1.21B	1.09B	780.70M	55.44M	543.19M	31.05M	110.60M
Weighted Average Basic & Diluted Shares Outstanding	210.58M	208.77M	206.27M	185.57M	166.94M	120.11M	776.20M	543.19M	434.67M	110.60M

This table shows Beigene's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	1.27	-152	-121	-120	-251	-368	215	-381	-348	-445	-558
Consolidated Net Income / (Loss)	1.27	-152	-121	-120	-251	-368	215	-381	-348	-445	-558
Net Income / (Loss) Continuing Operations	1.27	-152	-121	-120	-251	-368	215	-381	-348	-445	-558
Total Pre-Tax Income	21	-85	-98	-106	-243	-351	229	-367	-337	-431	-551
Total Operating Income	11	-79	-120	-107	-261	-384	-134	-319	-371	-469	-438
Total Gross Profit	952	967	831	791	627	529	685	499	366	307	311
Total Revenue	1,117	1,128	1,002	929	752	634	781	595	448	380	388
Operating Revenue	1,117	1,128	1,002	929	752	634	781	595	448	380	388
Total Cost of Revenue	165	161	170	138	125	106	96	96	82	74	77
Operating Cost of Revenue	165	161	170	138	125	106	96	96	82	74	77
Total Operating Expenses	941	1,047	951	898	888	912	819	818	737	775	749
Selling, General & Admin Expense	459	505	455	444	427	419	366	395	328	330	323
Research & Development Expense	482	542	496	454	461	494	453	423	409	446	426
Total Other Income / (Expense), net	9.80	-5.93	22	1.24	18	33	363	-49	34	38	-113
Interest & Investment Income	5.85	-	11	-	-	-	27	-	-	-	-
Other Income / (Expense), net	3.95	-14	11	-12	1.76	17	337	-64	18	19	-126
Income Tax Expense	20	67	23	14	7.72	17	14	14	11	14	6.32
Basic Earnings per Share	$0.00	($0.10)	($0.09)	($0.09)	($0.19)	($0.27)	$0.16	($0.28)	($0.26)	($0.33)	($0.41)
Weighted Average Basic Shares Outstanding	1.39B	1.37B	1.38B	1.36B	1.36B	1.36B	1.36B	1.36B	1.35B	1.34B	1.35B
Diluted Earnings per Share	$0.00	($0.10)	($0.09)	($0.09)	($0.19)	($0.26)	$0.15	($0.28)	($0.26)	($0.33)	($0.41)
Weighted Average Diluted Shares Outstanding	1.45B	1.37B	1.38B	1.36B	1.36B	1.36B	1.39B	1.36B	1.35B	1.34B	1.35B
Weighted Average Basic & Diluted Shares Outstanding	218.10M	210.58M	211.81M	209.40M	208.55M	208.77M	211.62M	209.27M	208.33M	206.27M	206.97M

This table details how cash moves in and out of Beigene's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	-547	-689	-508	2,993	769	-120	505	152	70	3.97
Net Cash From Operating Activities	-141	-1,157	-1,497	-1,299	-1,283	-750	-548	13	-90	-40
Net Cash From Continuing Operating Activities	-141	-1,157	-1,497	-1,299	-1,283	-750	-548	13	-90	-40
Net Income / (Loss) Continuing Operations	-645	-882	-2,004	-1,458	-1,629	-951	-674	-93	-119	-57
Consolidated Net Income / (Loss)	-645	-882	-2,004	-1,458	-1,629	-951	-674	-93	-119	-57
Depreciation Expense	172	88	66	46	32	19	10	4.76	1.91	1.55
Amortization Expense	-73	-55	-96	-112	-114	0.00	0.00	-	0.00	-
Non-Cash Adjustments To Reconcile Net Income	526	68	394	317	281	203	157	50	14	13
Changes in Operating Assets and Liabilities, net	-120	-376	143	-91	146	-21	-41	51	14	2.26
Net Cash From Investing Activities	-548	60	1,077	641	-3,168	554	-638	-356	-222	-59
Net Cash From Continuing Investing Activities	-548	60	1,077	641	-3,168	554	-638	-356	-222	-59
Purchase of Property, Plant & Equipment	-493	-562	-325	-263	-118	-90	-70	-46	-24	-5.31
Acquisitions	-36	-34	-144	-52	-110	-69	-109	0.00	0.00	-
Purchase of Investments	-19	-15	-16	-2,191	-5,690	-1,169	-2,636	-741	-382	-119
Sale and/or Maturity of Investments	2.66	673	1,564	3,147	2,751	1,882	2,177	424	184	66
Other Investing Activities, net	-2.86	-2.08	-1.49	-	-2.03	0.00	-	-12	0.00	0.00
Net Cash From Financing Activities	193	416	-19	3,637	5,203	86	1,691	490	381	103
Net Cash From Continuing Financing Activities	193	416	-19	3,637	5,203	86	1,691	490	381	103
Repayment of Debt	-729	-323	-417	-322	-144	-33	-8.74	-2.47	0.00	-0.32
Issuance of Debt	877	684	351	423	434	67	912	135	381	6.18
Issuance of Common Equity	45	56	47	3,535	4,325	51	787	354	0.00	0.00
Effect of Exchange Rate Changes	-52	-8.08	-69	14	-	-	-	5.30	0.10	-0.49
Cash Interest Paid	51	20	25	30	44	4.32	2.21	1.26	0.83	0.13
Cash Income Taxes Paid	69	56	30	16	11	8.98	12	29	0.03	0.00

This table details how cash moves in and out of Beigene's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	-108	-75	95	-190	-379	105	-341	-122	-331	-325	-335
Net Cash From Operating Activities	44	75	188	-96	-309	-222	-78	-294	-564	-318	-562
Net Cash From Continuing Operating Activities	44	75	188	-96	-309	-222	-78	-294	-564	-318	-562
Net Income / (Loss) Continuing Operations	1.27	-152	-121	-120	-251	-368	215	-381	-348	-445	-558
Consolidated Net Income / (Loss)	1.27	-152	-121	-120	-251	-368	215	-381	-348	-445	-558
Depreciation Expense	33	50	71	25	25	24	22	22	20	18	16
Amortization Expense	-20	-22	-17	-22	-13	-17	-16	-5.27	-17	-26	-25
Non-Cash Adjustments To Reconcile Net Income	95	192	118	131	85	141	-252	103	76	132	91
Changes in Operating Assets and Liabilities, net	-66	6.77	137	-109	-155	-2.12	-47	-32	-294	2.77	-87
Net Cash From Investing Activities	-122	-94	-134	-111	-210	-63	-186	68	241	39	169
Net Cash From Continuing Investing Activities	-122	-94	-134	-111	-210	-63	-186	68	241	39	169
Purchase of Property, Plant & Equipment	-56	-92	-134	-110	-157	-157	-158	-121	-126	-121	-109
Acquisitions	-60	-	-	-	-36	-9.95	-24	-	0.00	-49	-20
Sale and/or Maturity of Investments	1.80	-	-	-	2.66	106	0.02	191	377	211	301
Other Investing Activities, net	-7.33	18	-0.23	-1.08	-19	14	-4.00	-1.27	-10	-	-
Net Cash From Financing Activities	-34	-4.52	13	23	162	347	-77	166	-20	-110	120
Net Cash From Continuing Financing Activities	-34	-4.52	13	23	162	347	-77	166	-20	-110	120
Repayment of Debt	-177	-557	-3.56	-165	-3.58	-155	-101	-15	-51	-272	-30
Issuance of Debt	80	544	-	182	151	499	7.50	178	0.00	150	134
Issuance of Common Equity	63	8.80	16	5.56	15	3.36	17	3.58	32	11	17
Effect of Exchange Rate Changes	3.48	-52	28	-5.90	-22	42	-	-	-	65	-63
Cash Interest Paid	12	13	14	13	11	3.86	5.88	5.00	5.02	5.30	6.97
Cash Income Taxes Paid	9.32	15	9.14	43	2.49	13	9.99	25	7.62	4.49	0.57

This table presents Beigene's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	5,921	5,805	6,379	8,536	5,601	1,612	2,250	1,046	406	117
Total Current Assets	3,992	4,203	5,207	7,614	4,961	1,173	1,944	913	374	106
Cash & Equivalents	2,627	3,172	3,870	4,376	1,382	618	713	240	88	18
Accounts Receivable	676	358	173	483	60	71	41	29	0.00	-
Inventories, net	495	416	282	243	89	29	16	11	0.00	-
Prepaid Expenses	193	257	217	270	160	90	91	36	6.23	5.78
Plant, Property, & Equipment, net	1,578	1,324	846	588	358	242	157	63	26	6.61
Total Noncurrent Assets	351	278	326	334	282	197	149	70	5.44	3.88
Intangible Assets	51	57	41	47	5.00	5.85	7.17	7.25	0.00	-
Other Noncurrent Operating Assets	300	221	286	280	204	151	99	55	4.67	3.88
Total Liabilities & Shareholders' Equity	5,921	5,805	6,379	8,536	5,601	1,612	2,250	1,046	406	117
Total Liabilities	2,589	2,268	1,996	2,403	1,732	634	496	362	53	42
Total Current Liabilities	2,215	1,810	1,469	1,600	1,075	310	246	150	35	35
Short-Term Debt	852	688	329	428	335	0.00	8.73	9.22	0.00	15
Accounts Payable	405	315	295	262	232	122	113	119	12	8.98
Accrued Expenses	804	694	467	558	346	164	100	-	22	8.35
Current Deferred & Payable Income Tax Liabilities	26	23	25	21	20	13	5.89	9.16	0.80	0.00
Other Current Liabilities	129	90	138	143	142	11	-	-	-	2.17
Total Noncurrent Liabilities	374	458	527	803	656	324	250	212	18	7.27
Long-Term Debt	166	198	209	202	184	83	41	9.22	17	6.19
Noncurrent Deferred & Payable Income Tax Liabilities	42	16	16	14	11	11	11	0.00	-	-
Other Noncurrent Operating Liabilities	165	244	260	367	462	72	49	32	0.56	0.11
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	3,332	3,537	4,383	6,133	3,869	978	1,754	684	353	-102
Total Preferred & Common Equity	3,332	3,537	4,383	6,133	3,869	962	1,739	670	353	-102
Total Common Equity	3,332	3,537	4,383	6,133	3,869	962	1,739	670	353	-102
Common Stock	12,088	11,599	11,541	11,191	7,415	2,926	2,745	1,001	591	18
Retained Earnings	-8,607	-7,962	-7,080	-5,077	-3,553	-1,956	-1,007	-331	-237	-118
Accumulated Other Comprehensive Income / (Loss)	-149	-99	-77	18	6.94	-8.00	1.53	-0.48	-0.95	-1.81

This table presents Beigene's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/30/2022
Total Assets	5,842	5,831	5,712	5,668	5,525	5,729	5,957	6,726
Total Current Assets	3,896	3,912	3,839	3,908	4,054	4,401	4,704	5,749
Cash & Equivalents	2,516	2,702	2,593	2,793	3,067	3,410	3,539	4,197
Accounts Receivable	717	569	529	435	309	299	310	189
Inventories, net	495	432	443	447	317	321	297	291
Prepaid Expenses	168	209	274	232	242	255	265	200
Plant, Property, & Equipment, net	1,599	1,563	1,516	1,418	1,178	1,032	925	682
Total Noncurrent Assets	346	356	357	342	293	295	327	295
Intangible Assets	50	54	54	55	54	47	40	41
Other Noncurrent Operating Assets	296	302	303	287	240	247	282	251
Total Liabilities & Shareholders' Equity	5,842	5,831	5,712	5,668	5,525	5,729	5,957	6,726
Total Liabilities	2,342	2,395	2,346	2,307	1,762	1,930	1,799	2,071
Total Current Liabilities	1,984	2,025	1,939	1,882	1,283	1,405	1,255	1,411
Short-Term Debt	763	864	852	827	329	421	282	441
Accounts Payable	364	308	333	357	342	267	241	252
Accrued Expenses	692	717	647	569	506	455	418	410
Current Deferred & Payable Income Tax Liabilities	34	15	5.28	27	20	17	34	23
Other Current Liabilities	129	122	102	101	87	86	94	140
Total Noncurrent Liabilities	358	369	407	426	478	525	545	660
Long-Term Debt	160	188	185	199	202	207	206	208
Noncurrent Deferred & Payable Income Tax Liabilities	43	16	16	16	16	16	16	15
Other Noncurrent Operating Liabilities	155	166	206	210	259	278	285	286
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	3,500	3,436	3,366	3,360	3,763	3,799	4,157	4,655
Total Preferred & Common Equity	3,500	3,436	3,366	3,360	3,763	3,799	4,157	4,655
Total Common Equity	3,500	3,436	3,366	3,360	3,763	3,799	4,157	4,655
Common Stock	12,247	11,975	11,840	11,705	11,503	11,752	11,645	11,452
Retained Earnings	-8,606	-8,455	-8,334	-8,213	-7,594	-7,810	-7,429	-6,635
Accumulated Other Comprehensive Income / (Loss)	-142	-84	-140	-132	-145	-144	-59	-162

This table displays calculated financial ratios and metrics derived from Beigene's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	54.96%	73.65%	20.37%	280.83%	-27.87%	116.03%	-16.85%	22,179.16%	-87.86%	-32.37%
EBITDA Growth	44.40%	57.55%	-37.26%	12.54%	-82.25%	-34.72%	-743.56%	30.13%	-109.63%	-243.01%
EBIT Growth	35.45%	55.31%	-41.51%	12.18%	-70.06%	-35.37%	-709.35%	27.26%	-107.33%	-221.82%
NOPAT Growth	52.95%	32.52%	-24.39%	13.21%	-72.69%	-36.01%	-616.83%	15.89%	-106.29%	-260.13%
Net Income Growth	26.87%	56.00%	-37.45%	10.49%	-71.33%	-41.03%	-622.44%	21.74%	-108.78%	-207.89%
EPS Growth	27.69%	56.38%	-23.14%	19.33%	-22.95%	-31.18%	-447.06%	43.33%	42.31%	-188.89%
Operating Cash Flow Growth	87.85%	22.66%	-15.24%	-1.19%	-71.07%	-36.98%	-4,395.15%	114.25%	-124.66%	-358.28%
Free Cash Flow Firm Growth	49.19%	-13.89%	-6.11%	-115.75%	13.98%	-21.94%	-698.43%	12.32%	-160.16%	0.00%
Invested Capital Growth	37.66%	223.84%	181.28%	150.73%	-215.97%	63.52%	1,149.56%	466.68%	137.48%	0.00%
Revenue Q/Q Growth	14.88%	11.54%	13.29%	10.72%	16.26%	-0.41%	25.68%	8.25%	-81.38%	0.00%
EBITDA Q/Q Growth	37.99%	10.08%	6.48%	-7.29%	-7.94%	-11.86%	-36.67%	-195.27%	-9.78%	0.00%
EBIT Q/Q Growth	32.04%	8.36%	6.20%	-8.01%	-6.36%	-11.56%	-36.28%	-180.37%	-9.66%	0.00%
NOPAT Q/Q Growth	34.88%	6.56%	5.45%	-6.42%	-6.21%	-12.58%	-33.48%	-208.36%	-10.26%	0.00%
Net Income Q/Q Growth	25.06%	8.11%	7.42%	-7.77%	-7.44%	-14.61%	-33.05%	-195.09%	-9.51%	0.00%
EPS Q/Q Growth	25.40%	9.72%	10.24%	0.00%	0.00%	-12.96%	-29.17%	-54.55%	34.78%	0.00%
Operating Cash Flow Q/Q Growth	67.85%	7.70%	11.25%	-15.63%	-5.35%	-10.83%	-110.60%	111.90%	-11.70%	0.00%
Free Cash Flow Firm Q/Q Growth	32.52%	3.97%	-1.48%	-13.31%	-10.53%	3.69%	-120.96%	57.77%	0.00%	0.00%
Invested Capital Q/Q Growth	-3.51%	12.91%	66.58%	78.34%	-19.98%	-14.56%	82.34%	-93.09%	-10.12%	0.00%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	84.41%	84.55%	79.77%	85.98%	77.12%	83.38%	85.52%	97.91%	100.00%	100.00%
EBITDA Margin	-12.66%	-35.28%	-144.33%	-126.57%	-551.16%	-218.14%	-349.81%	-34.48%	-10,994.11%	-636.52%
Operating Margin	-14.91%	-49.12%	-126.40%	-122.31%	-536.69%	-224.16%	-356.05%	-41.30%	-10,940.19%	-643.66%
EBIT Margin	-15.24%	-36.60%	-142.21%	-120.96%	-524.55%	-222.49%	-355.05%	-36.48%	-11,172.52%	-654.05%
Profit (Net Income) Margin	-16.92%	-35.86%	-141.52%	-123.93%	-527.27%	-221.99%	-340.04%	-39.14%	-11,141.78%	-647.71%
Tax Burden Percent	120.97%	106.77%	102.18%	101.34%	100.64%	100.74%	97.71%	102.45%	100.05%	100.00%
Interest Burden Percent	91.76%	91.78%	97.39%	101.11%	99.88%	99.04%	98.02%	104.72%	99.68%	99.03%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	-26.74%	-103.23%	-478.29%	0.00%	0.00%	-357.05%	-640.55%	-1,025.06%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	-14.06%	-102.07%	-463.26%	0.00%	0.00%	-333.39%	-624.78%	-1,020.30%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	7.97%	80.96%	440.18%	0.00%	0.00%	287.46%	585.25%	1,007.07%	0.00%	0.00%
Return on Equity (ROE)	-18.77%	-22.26%	-38.11%	-29.15%	-67.19%	-69.59%	-55.30%	-17.99%	-55.81%	-76.83%
Cash Return on Invested Capital (CROIC)	-58.44%	-208.85%	-573.38%	-1,030.15%	0.00%	-405.26%	-810.91%	-1,165.06%	-4,429.35%	0.00%
Operating Return on Assets (OROA)	-9.91%	-14.77%	-27.00%	-20.13%	-44.92%	-49.34%	-42.70%	-11.98%	-45.75%	-49.38%
Return on Assets (ROA)	-11.00%	-14.47%	-26.87%	-20.63%	-45.16%	-49.23%	-40.90%	-12.85%	-45.63%	-48.90%
Return on Common Equity (ROCE)	-18.77%	-22.26%	-38.11%	-29.15%	-66.97%	-68.81%	-54.64%	-17.74%	-32.81%	105.21%
Return on Equity Simple (ROE_SIMPLE)	-19.35%	-24.93%	-45.71%	-23.77%	-42.09%	-98.79%	-38.76%	-13.93%	-33.78%	56.11%
Net Operating Profit after Tax (NOPAT)	-398	-845	-1,253	-1,007	-1,160	-672	-494	-69	-82	-40
NOPAT Margin	-10.44%	-34.38%	-88.48%	-85.62%	-375.68%	-156.91%	-249.24%	-28.91%	-7,658.13%	-450.56%
Net Nonoperating Expense Percent (NNEP)	-12.68%	-1.16%	-15.03%	-8.89%	-19.17%	-23.66%	-15.76%	-4.76%	-17.31%	-43.61%
Return On Investment Capital (ROIC_SIMPLE)	-9.14%	-19.11%	-25.46%	-14.89%	-26.45%	-63.29%	-27.40%	-9.81%	-22.14%	49.05%
Cost of Revenue to Revenue	15.59%	15.45%	20.23%	14.02%	22.88%	16.62%	14.48%	2.09%	0.00%	0.00%
SG&A Expenses to Revenue	48.06%	61.33%	90.30%	84.17%	194.31%	90.67%	98.57%	26.26%	1,878.22%	82.93%
R&D to Revenue	51.26%	72.34%	115.86%	124.06%	419.23%	216.56%	342.55%	112.85%	9,161.96%	660.73%
Operating Expenses to Revenue	99.32%	133.67%	206.16%	208.29%	613.81%	307.54%	441.57%	139.21%	11,040.19%	743.66%
Earnings before Interest and Taxes (EBIT)	-581	-900	-2,014	-1,423	-1,620	-953	-704	-87	-120	-58
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-482	-867	-2,044	-1,489	-1,702	-934	-693	-82	-118	-56
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	5.91	5.33	5.21	4.15	6.08	10.45	4.79	6.63	2.84	0.00
Price to Tangible Book Value (P/TBV)	6.00	5.42	5.26	4.18	6.08	10.51	4.81	6.71	2.84	0.00
Price to Revenue (P/Rev)	5.17	7.67	16.13	21.61	76.12	23.47	42.04	18.64	937.41	0.00
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	10.50	13.24	48.74	141.43	0.00	39.26	46.22	318.32	323.32	0.00
Enterprise Value to Revenue (EV/Rev)	4.75	6.74	13.30	16.52	62.74	21.41	33.30	15.26	609.48	0.00
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	285.32	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.31	0.25	0.12	0.10	0.13	0.09	0.03	0.03	0.05	0.28
Long-Term Debt to Equity	0.05	0.06	0.05	0.03	0.05	0.09	0.02	0.01	0.05	0.08
Financial Leverage	-0.57	-0.79	-0.95	-1.01	-1.01	-0.86	-0.94	-0.99	-1.01	-1.07
Leverage Ratio	1.71	1.54	1.42	1.41	1.49	1.41	1.35	1.40	1.22	1.57
Compound Leverage Factor	1.57	1.41	1.38	1.43	1.49	1.40	1.33	1.47	1.22	1.56
Debt to Total Capital	23.40%	20.03%	10.93%	9.31%	11.82%	7.85%	2.75%	2.62%	4.67%	21.86%
Short-Term Debt to Total Capital	19.57%	15.56%	6.68%	6.32%	7.64%	0.00%	0.48%	1.31%	0.00%	15.35%
Long-Term Debt to Total Capital	3.83%	4.47%	4.25%	2.99%	4.19%	7.85%	2.26%	1.31%	4.67%	6.51%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	1.52%	0.80%	2.05%	0.00%	185.15%
Common Equity to Total Capital	76.60%	79.97%	89.07%	90.69%	88.18%	90.63%	96.45%	95.32%	95.33%	-107.00%
Debt to EBITDA	-2.11	-1.02	-0.26	-0.42	-0.30	-0.09	-0.07	-0.22	-0.15	-0.37
Net Debt to EBITDA	3.34	2.64	1.96	4.02	2.43	0.96	2.52	9.96	2.98	1.42
Long-Term Debt to EBITDA	-0.35	-0.23	-0.10	-0.14	-0.11	-0.09	-0.06	-0.11	-0.15	-0.11
Debt to NOPAT	-2.56	-1.05	-0.43	-0.63	-0.45	-0.12	-0.10	-0.27	-0.21	-0.52
Net Debt to NOPAT	4.05	2.70	3.19	5.95	3.56	1.34	3.54	11.88	4.28	2.01
Long-Term Debt to NOPAT	-0.42	-0.23	-0.17	-0.20	-0.16	-0.12	-0.08	-0.13	-0.21	-0.16
Altman Z-Score	3.21	3.48	5.19	5.95	7.19	6.77	9.41	7.75	10.59	0.00
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.33%	1.12%	1.18%	1.39%	41.22%	236.93%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.80	2.32	3.55	4.76	4.61	3.78	7.89	6.09	10.68	3.02
Quick Ratio	1.49	1.95	3.21	4.44	4.38	3.40	7.40	5.78	10.50	2.86
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-869	-1,710	-1,502	-1,415	-656	-763	-625	-78	-89	-34
Operating Cash Flow to CapEx	-28.55%	-205.99%	-459.88%	-493.92%	-1,092.23%	-837.24%	-779.30%	27.50%	-380.94%	-749.92%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	-89.82	0.00	0.00	0.00	-19.07	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	-82.42	0.00	0.00	0.00	3.10	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	-99.11	0.00	0.00	0.00	-8.18	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.65	0.40	0.19	0.17	0.09	0.22	0.12	0.33	0.00	0.08
Accounts Receivable Turnover	7.37	9.26	4.32	4.33	4.71	7.65	5.62	0.00	0.00	0.00
Inventory Turnover	1.30	1.09	1.09	0.99	1.20	3.18	2.11	0.00	0.00	0.00
Fixed Asset Turnover	2.63	2.27	1.98	2.49	1.03	2.14	1.81	5.38	0.07	1.33
Accounts Payable Turnover	1.65	1.25	1.03	0.67	0.40	0.60	0.25	0.08	0.00	0.00
Days Sales Outstanding (DSO)	49.54	39.43	84.59	84.33	77.57	47.71	64.89	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	279.89	335.52	334.44	367.33	304.38	114.83	172.75	0.00	0.00	0.00
Days Payable Outstanding (DPO)	221.21	292.97	354.95	547.10	915.50	604.41	1,479.20	4,818.75	0.00	0.00
Cash Conversion Cycle (CCC)	108.21	81.98	64.07	-95.44	-533.54	-441.87	-1,241.55	-4,818.75	0.00	0.00
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,723	1,252	386	137	-271	234	143	11	2.02	-5.38
Invested Capital Turnover	2.56	3.00	5.41	-17.63	-16.57	2.28	2.57	35.46	-0.64	-3.28
Increase / (Decrease) in Invested Capital	471	865	249	408	-504	91	131	9.41	7.40	-5.38
Enterprise Value (EV)	18,084	16,576	18,837	19,432	19,380	9,168	6,601	3,638	652	0.00
Market Capitalization	19,693	18,861	22,834	25,420	23,512	10,052	8,333	4,443	1,003	0.00
Book Value per Share	$2.40	$2.60	$3.25	$5.03	$3.27	$1.22	$2.25	$1.13	$0.82	($0.92)
Tangible Book Value per Share	$2.37	$2.56	$3.22	$4.99	$3.27	$1.21	$2.24	$1.12	$0.82	($0.92)
Total Capital	4,350	4,423	4,921	6,762	4,388	1,062	1,803	703	370	95
Total Debt	1,018	886	538	630	519	83	50	18	17	21
Total Long-Term Debt	166	198	209	202	184	83	41	9.22	17	6.19
Net Debt	-1,609	-2,286	-3,997	-5,988	-4,132	-900	-1,746	-819	-351	-80
Capital Expenditures (CapEx)	493	562	325	263	118	90	70	46	23	5.31
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.81	-90	-467	-176	-430	-121	-90	-65	-29	-15
Debt-free Net Working Capital (DFNWC)	2,628	3,082	4,068	6,442	4,221	862	1,706	773	339	86
Net Working Capital (NWC)	1,777	2,393	3,739	6,014	3,885	862	1,697	764	339	71
Net Nonoperating Expense (NNE)	247	36	751	451	468	279	180	24	37	17
Net Nonoperating Obligations (NNO)	-1,609	-2,286	-3,997	-5,995	-4,140	-745	-1,611	-673	-351	-80
Total Depreciation and Amortization (D&A)	99	32	-30	-66	-82	19	10	4.76	1.91	1.55
Debt-free, Cash-free Net Working Capital to Revenue	0.02%	-3.67%	-33.02%	-14.97%	-139.37%	-28.17%	-45.34%	-27.18%	-2,694.67%	-167.77%
Debt-free Net Working Capital to Revenue	68.98%	125.33%	287.27%	547.65%	1,366.42%	201.39%	860.72%	324.15%	31,714.11%	972.04%
Net Working Capital to Revenue	46.63%	97.34%	264.04%	511.30%	1,257.95%	201.39%	856.32%	320.28%	31,714.11%	806.45%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.47)	($0.65)	($1.49)	($1.17)	($1.47)	($1.22)	($0.93)	($0.17)	($0.30)	($0.52)
Adjusted Weighted Average Basic Shares Outstanding	1.37B	1.36B	1.34B	1.21B	1.19B	1.01B	776.11M	696.34M	518.60M	110.60M
Adjusted Diluted Earnings per Share	($0.47)	($0.65)	($1.49)	($1.17)	($1.47)	($1.22)	($0.93)	($0.17)	($0.30)	($0.52)
Adjusted Weighted Average Diluted Shares Outstanding	1.37B	1.36B	1.34B	1.21B	1.19B	1.01B	776.11M	696.34M	518.60M	110.60M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	($1.47)	($1.22)	($0.93)	($0.17)	($0.30)	($0.52)
Adjusted Weighted Average Basic & Diluted Shares Outstanding	210.58M	208.77M	206.27M	185.57M	1.17B	780.70M	776.20M	543.19M	403.62M	110.60M
Normalized Net Operating Profit after Tax (NOPAT)	-398	-845	-1,253	-1,007	-1,160	-672	-494	-69	-82	-40
Normalized NOPAT Margin	-10.44%	-34.38%	-88.48%	-85.62%	-375.68%	-156.91%	-249.24%	-28.91%	-7,658.13%	-450.56%
Pre Tax Income Margin	-13.99%	-33.59%	-138.50%	-122.30%	-523.90%	-220.35%	-348.01%	-38.20%	-11,136.73%	-647.71%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	-90.30	0.00	0.00	0.00	-21.17	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	-63.92	0.00	0.00	0.00	-16.78	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	-106.99	0.00	0.00	0.00	-32.46	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	-80.60	0.00	0.00	0.00	-28.07	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-0.72%	-1.86%	0.00%

This table displays calculated financial ratios and metrics derived from Beigene's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	48.64%	77.78%	28.20%	56.09%	67.85%	66.91%	101.56%	74.27%	46.04%	77.63%	87.77%
EBITDA Growth	111.33%	82.07%	-126.03%	68.23%	29.38%	21.27%	136.38%	36.70%	19.75%	23.66%	-27.92%
EBIT Growth	105.80%	74.62%	-153.75%	68.85%	26.45%	18.29%	135.94%	32.77%	18.17%	22.86%	-30.90%
NOPAT Growth	100.37%	79.31%	33.10%	66.38%	29.60%	18.10%	58.99%	27.47%	16.25%	18.04%	5.18%
Net Income Growth	100.51%	58.68%	-156.33%	68.41%	27.92%	17.47%	138.64%	32.63%	19.94%	26.49%	-27.26%
EPS Growth	100.00%	61.54%	-160.00%	67.86%	26.92%	21.21%	136.59%	33.33%	21.21%	34.00%	-13.89%
Operating Cash Flow Growth	114.29%	133.91%	341.04%	67.47%	45.27%	30.34%	86.09%	22.65%	-138.32%	37.34%	-13.35%
Free Cash Flow Firm Growth	67.67%	53.52%	24.05%	-2.43%	-17.34%	-96.45%	-117.03%	-54.27%	-6.92%	28.62%	26.28%
Invested Capital Growth	19.70%	37.66%	61.08%	101.22%	97.25%	223.84%	377.78%	460.55%	233.36%	181.28%	201.14%
Revenue Q/Q Growth	-0.94%	12.60%	7.80%	23.62%	18.48%	-18.80%	31.25%	32.93%	17.81%	-1.94%	13.48%
EBITDA Q/Q Growth	143.46%	-18.98%	53.30%	53.07%	31.26%	-272.81%	157.00%	-4.32%	23.37%	20.16%	0.82%
EBIT Q/Q Growth	116.16%	14.49%	8.56%	54.10%	29.28%	-281.09%	152.99%	-8.38%	21.42%	20.36%	0.88%
NOPAT Q/Q Growth	101.21%	33.96%	-12.23%	59.00%	31.90%	-113.50%	43.60%	14.15%	20.78%	-6.90%	0.24%
Net Income Q/Q Growth	100.84%	-25.16%	-0.78%	52.06%	31.67%	-270.63%	156.52%	-9.39%	21.76%	20.13%	1.44%
EPS Q/Q Growth	100.00%	-11.11%	0.00%	52.63%	26.92%	-273.33%	153.57%	-7.69%	21.21%	19.51%	2.38%
Operating Cash Flow Q/Q Growth	-41.35%	-60.10%	297.06%	69.02%	-39.22%	-183.61%	73.41%	47.87%	-77.18%	43.37%	-47.89%
Free Cash Flow Firm Q/Q Growth	40.58%	30.78%	22.78%	-1.80%	14.59%	-13.12%	-4.15%	-16.62%	-42.99%	-24.97%	25.97%
Invested Capital Q/Q Growth	10.67%	-3.51%	-1.38%	13.66%	27.28%	12.91%	23.19%	11.41%	108.97%	66.58%	44.53%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	85.23%	85.76%	82.98%	85.13%	83.38%	83.32%	87.67%	83.87%	81.74%	80.66%	80.25%
EBITDA Margin	2.51%	-5.72%	-5.41%	-12.50%	-32.92%	-56.74%	26.66%	-61.40%	-78.24%	-120.28%	-147.72%
Operating Margin	0.99%	-7.04%	-12.01%	-11.53%	-34.77%	-60.50%	-17.15%	-53.54%	-82.91%	-123.29%	-113.09%
EBIT Margin	1.35%	-8.26%	-10.88%	-12.82%	-34.54%	-57.86%	25.94%	-64.26%	-78.82%	-118.18%	-145.50%
Profit (Net Income) Margin	0.11%	-13.47%	-12.12%	-12.96%	-33.41%	-57.94%	27.57%	-64.03%	-77.81%	-117.16%	-143.84%
Tax Burden Percent	6.08%	177.95%	123.44%	113.68%	103.17%	104.78%	93.93%	103.72%	103.41%	103.33%	101.15%
Interest Burden Percent	138.85%	91.62%	90.23%	88.90%	93.77%	95.57%	113.15%	96.06%	95.46%	95.94%	97.74%
Effective Tax Rate	93.92%	0.00%	0.00%	0.00%	0.00%	0.00%	6.07%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.14%	-12.63%	-19.27%	-18.45%	-56.02%	-127.14%	-52.98%	-128.02%	-172.15%	-466.54%	-640.29%
ROIC Less NNEP Spread (ROIC-NNEP)	0.11%	-7.69%	-17.54%	-16.41%	-53.35%	-123.99%	-62.62%	-124.09%	-170.18%	-464.19%	-633.79%
Return on Net Nonoperating Assets (RNNOA)	-0.05%	4.36%	10.49%	10.20%	36.32%	98.35%	52.65%	109.63%	152.39%	441.07%	609.34%
Return on Equity (ROE)	0.09%	-8.27%	-8.78%	-8.25%	-19.70%	-28.79%	-0.33%	-18.39%	-19.76%	-25.47%	-30.95%
Cash Return on Invested Capital (CROIC)	-29.76%	-58.44%	-89.00%	-112.99%	-129.46%	-208.85%	-265.77%	-350.31%	-336.75%	-573.38%	-957.77%
Operating Return on Assets (OROA)	0.98%	-5.37%	-6.35%	-6.94%	-16.42%	-23.35%	9.34%	-17.76%	-17.56%	-22.44%	-30.28%
Return on Assets (ROA)	0.08%	-8.75%	-7.08%	-7.01%	-15.88%	-23.38%	9.92%	-17.69%	-17.34%	-22.25%	-29.93%
Return on Common Equity (ROCE)	0.09%	-8.27%	-8.78%	-8.25%	-19.70%	-28.79%	-0.33%	-18.39%	-19.76%	-25.47%	-30.95%
Return on Equity Simple (ROE_SIMPLE)	-11.21%	0.00%	-25.04%	-15.56%	-23.34%	0.00%	-25.50%	-45.61%	-46.11%	0.00%	-46.49%
Net Operating Profit after Tax (NOPAT)	0.67	-56	-84	-75	-183	-269	-126	-223	-260	-328	-307
NOPAT Margin	0.06%	-4.93%	-8.41%	-8.07%	-24.34%	-42.35%	-16.11%	-37.48%	-58.03%	-86.30%	-79.16%
Net Nonoperating Expense Percent (NNEP)	0.04%	-4.94%	-1.73%	-2.04%	-2.67%	-3.15%	9.64%	-3.93%	-1.97%	-2.35%	-6.51%
Return On Investment Capital (ROIC_SIMPLE)	0.02%	-1.28%	-1.88%	-1.70%	-4.17%	-6.07%	-2.93%	-5.04%	-5.59%	-6.67%	-5.78%
Cost of Revenue to Revenue	14.77%	14.24%	17.02%	14.87%	16.62%	16.68%	12.33%	16.13%	18.26%	19.34%	19.75%
SG&A Expenses to Revenue	41.11%	44.75%	45.45%	47.76%	56.87%	66.01%	46.81%	66.36%	73.36%	86.75%	83.30%
R&D to Revenue	43.13%	48.06%	49.54%	48.91%	61.28%	77.87%	58.01%	71.02%	91.24%	117.35%	109.99%
Operating Expenses to Revenue	84.24%	92.81%	94.99%	96.67%	118.15%	143.81%	104.82%	137.42%	164.64%	203.95%	193.34%
Earnings before Interest and Taxes (EBIT)	15	-93	-109	-119	-260	-367	203	-383	-353	-449	-564
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	28	-65	-54	-116	-247	-360	208	-365	-350	-457	-573
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	8.30	5.91	6.93	4.43	4.87	5.33	5.06	4.92	5.41	5.21	3.01
Price to Tangible Book Value (P/TBV)	8.42	6.00	7.04	4.50	4.95	5.42	5.13	4.98	5.46	5.26	3.03
Price to Revenue (P/Rev)	6.96	5.17	7.18	4.82	5.92	7.67	8.64	10.32	14.44	16.13	11.20
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	14.40	10.50	12.42	7.38	9.16	13.24	14.78	17.55	23.70	48.74	41.28
Enterprise Value to Revenue (EV/Rev)	6.57	4.75	6.69	4.32	5.28	6.74	7.43	8.72	12.29	13.30	7.66
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	129.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.26	0.31	0.31	0.31	0.31	0.25	0.14	0.17	0.12	0.12	0.14
Long-Term Debt to Equity	0.05	0.05	0.05	0.06	0.06	0.06	0.05	0.05	0.05	0.05	0.04
Financial Leverage	-0.49	-0.57	-0.60	-0.62	-0.68	-0.79	-0.84	-0.88	-0.90	-0.95	-0.96
Leverage Ratio	1.68	1.71	1.58	1.60	1.55	1.54	1.46	1.44	1.39	1.42	1.50
Compound Leverage Factor	2.33	1.56	1.42	1.42	1.45	1.47	1.65	1.38	1.33	1.36	1.47
Debt to Total Capital	20.88%	23.40%	23.43%	23.55%	23.39%	20.03%	12.37%	14.20%	10.51%	10.93%	12.24%
Short-Term Debt to Total Capital	17.26%	19.57%	19.25%	19.34%	18.85%	15.56%	7.65%	9.51%	6.07%	6.68%	8.32%
Long-Term Debt to Total Capital	3.62%	3.83%	4.18%	4.21%	4.54%	4.47%	4.72%	4.69%	4.44%	4.25%	3.92%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	79.12%	76.60%	76.57%	76.45%	76.61%	79.97%	87.63%	85.80%	89.49%	89.07%	87.76%
Debt to EBITDA	-4.47	-2.11	-1.35	-2.01	-1.34	-1.02	-0.55	-0.36	-0.25	-0.26	-0.30
Net Debt to EBITDA	7.70	3.34	2.12	3.02	2.31	2.64	2.75	1.66	1.71	1.96	2.02
Long-Term Debt to EBITDA	-0.77	-0.35	-0.24	-0.36	-0.26	-0.23	-0.21	-0.12	-0.11	-0.10	-0.10
Debt to NOPAT	-4.46	-2.56	-1.72	-1.67	-1.34	-1.05	-0.59	-0.56	-0.41	-0.43	-0.49
Net Debt to NOPAT	7.69	4.05	2.70	2.51	2.30	2.70	2.93	2.59	2.78	3.19	3.34
Long-Term Debt to NOPAT	-0.77	-0.42	-0.31	-0.30	-0.26	-0.23	-0.22	-0.19	-0.17	-0.17	-0.16
Altman Z-Score	6.50	3.48	4.83	2.65	2.99	3.78	5.68	4.62	6.51	6.00	3.36
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.96	1.80	1.93	1.98	2.08	2.32	3.16	3.13	3.75	3.55	4.07
Quick Ratio	1.63	1.49	1.62	1.61	1.72	1.95	2.71	2.72	3.30	3.21	3.73
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-313	-527	-761	-986	-968	-1,134	-1,002	-962	-825	-577	-462
Operating Cash Flow to CapEx	78.15%	81.27%	140.94%	-86.94%	-197.07%	-141.21%	-49.50%	-241.94%	-448.92%	-262.19%	-517.15%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.73	0.65	0.58	0.54	0.48	0.40	0.36	0.28	0.22	0.19	0.21
Accounts Receivable Turnover	7.25	7.37	7.55	7.47	7.42	9.26	8.85	7.68	6.22	4.32	7.84
Inventory Turnover	1.35	1.30	1.44	1.22	1.14	1.09	1.14	1.12	1.12	1.09	1.18
Fixed Asset Turnover	2.77	2.63	2.42	2.43	2.36	2.27	2.37	2.18	2.01	1.98	2.21
Accounts Payable Turnover	1.76	1.65	1.66	1.55	1.42	1.25	1.17	1.31	1.27	1.03	1.14
Days Sales Outstanding (DSO)	50.37	49.54	48.32	48.84	49.21	39.43	41.25	47.52	58.65	84.59	46.55
Days Inventory Outstanding (DIO)	271.09	279.89	253.30	299.95	321.09	335.52	319.12	324.84	326.80	334.44	308.40
Days Payable Outstanding (DPO)	207.51	221.21	219.73	235.38	257.93	292.97	311.82	279.07	288.04	354.95	319.83
Cash Conversion Cycle (CCC)	113.95	108.21	81.89	113.41	112.37	81.98	48.55	93.29	97.41	64.07	35.11
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,907	1,723	1,785	1,811	1,593	1,252	1,108	900	808	386	232
Invested Capital Turnover	2.39	2.56	2.29	2.29	2.30	3.00	3.29	3.42	2.97	5.41	8.09
Increase / (Decrease) in Invested Capital	314	471	677	911	785	865	876	739	565	249	155
Enterprise Value (EV)	27,453	18,084	22,174	13,365	14,587	16,576	16,387	15,792	19,139	18,837	9,577
Market Capitalization	29,046	19,693	23,824	14,920	16,355	18,861	19,042	18,689	22,484	22,834	13,997
Book Value per Share	$2.52	$2.40	$2.49	$2.48	$2.48	$2.60	$2.73	$2.79	$3.07	$3.25	$3.45
Tangible Book Value per Share	$2.48	$2.37	$2.45	$2.44	$2.44	$2.56	$2.70	$2.75	$3.04	$3.22	$3.42
Total Capital	4,423	4,350	4,487	4,403	4,386	4,423	4,294	4,427	4,645	4,921	5,305
Total Debt	924	1,018	1,051	1,037	1,026	886	531	628	488	538	649
Total Long-Term Debt	160	166	188	185	199	198	202	207	206	209	208
Net Debt	-1,593	-1,609	-1,651	-1,556	-1,767	-2,286	-2,655	-2,897	-3,345	-3,997	-4,420
Capital Expenditures (CapEx)	56	92	134	110	157	157	158	121	126	121	109
Debt-free, Cash-free Net Working Capital (DFCFNWC)	160	0.81	48	159	60	-90	-87	-108	-101	-467	-290
Debt-free Net Working Capital (DFNWC)	2,676	2,628	2,750	2,752	2,853	3,082	3,099	3,417	3,732	4,068	4,779
Net Working Capital (NWC)	1,913	1,777	1,886	1,900	2,026	2,393	2,770	2,996	3,450	3,739	4,338
Net Nonoperating Expense (NNE)	-0.60	96	37	45	68	99	-341	158	89	117	251
Net Nonoperating Obligations (NNO)	-1,593	-1,609	-1,651	-1,556	-1,767	-2,286	-2,655	-2,899	-3,350	-3,997	-4,423
Total Depreciation and Amortization (D&A)	13	29	55	3.03	12	7.09	5.61	17	2.61	-8.00	-8.61
Debt-free, Cash-free Net Working Capital to Revenue	3.83%	0.02%	1.46%	5.14%	2.16%	-3.67%	-3.95%	-5.99%	-6.50%	-33.02%	-23.22%
Debt-free Net Working Capital to Revenue	64.09%	68.98%	82.92%	88.87%	103.27%	125.33%	140.57%	188.72%	239.65%	287.27%	382.39%
Net Working Capital to Revenue	45.81%	46.63%	56.87%	61.37%	73.34%	97.34%	125.67%	165.47%	221.55%	264.04%	347.08%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($0.10)	($0.09)	($0.09)	($0.19)	($0.27)	$0.16	($0.28)	($0.26)	($0.33)	($0.41)
Adjusted Weighted Average Basic Shares Outstanding	1.39B	1.37B	1.38B	1.36B	1.36B	1.36B	1.36B	1.36B	1.35B	1.34B	1.35B
Adjusted Diluted Earnings per Share	$0.00	($0.10)	($0.09)	($0.09)	($0.19)	($0.26)	$0.15	($0.28)	($0.26)	($0.33)	($0.41)
Adjusted Weighted Average Diluted Shares Outstanding	1.45B	1.37B	1.38B	1.36B	1.36B	1.36B	1.39B	1.36B	1.35B	1.34B	1.35B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	218.10M	210.58M	211.81M	209.40M	208.55M	208.77M	211.62M	209.27M	208.33M	206.27M	206.97M
Normalized Net Operating Profit after Tax (NOPAT)	7.77	-56	-84	-75	-183	-269	-126	-223	-260	-328	-307
Normalized NOPAT Margin	0.70%	-4.93%	-8.41%	-8.07%	-24.34%	-42.35%	-16.11%	-37.48%	-58.03%	-86.30%	-79.16%
Pre Tax Income Margin	1.87%	-7.57%	-9.81%	-11.40%	-32.39%	-55.29%	29.35%	-61.73%	-75.24%	-113.38%	-142.21%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Beigene's Financials

When does Beigene's financial year end?

According to the most recent income statement we have on file, Beigene's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Beigene's net income changed over the last 9 years?

Beigene's net income appears to be on an upward trend, with a most recent value of -$644.79 million in 2024, rising from -$57.10 million in 2015. The previous period was -$881.71 million in 2023. Check out Beigene's forecast to explore projected trends and price targets.

What is Beigene's operating income?

Beigene's total operating income in 2024 was -$568.20 million, based on the following breakdown:

Total Gross Profit: $3.22 billion
Total Operating Expenses: $3.78 billion

How has Beigene revenue changed over the last 9 years?

Over the last 9 years, Beigene's total revenue changed from $8.82 million in 2015 to $3.81 billion in 2024, a change of 43,119.6%.

How much debt does Beigene have?

Beigene's total liabilities were at $2.59 billion at the end of 2024, a 14.1% increase from 2023, and a 5,998.9% increase since 2015.

How much cash does Beigene have?

In the past 9 years, Beigene's cash and equivalents has ranged from $17.87 million in 2015 to $4.38 billion in 2021, and is currently $2.63 billion as of their latest financial filing in 2024.

How has Beigene's book value per share changed over the last 9 years?

Over the last 9 years, Beigene's book value per share changed from -0.92 in 2015 to 2.40 in 2024, a change of -361.3%.

Related Companies

This page (NASDAQ:ONC) was last updated on 5/23/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Beigene (ONC) Financials

Frequently Asked Questions About Beigene's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Beigene (ONC) Financials

Annual Income Statements for Beigene

Quarterly Income Statements for Beigene

Annual Cash Flow Statements for Beigene

Quarterly Cash Flow Statements for Beigene

Annual Balance Sheets for Beigene

Quarterly Balance Sheets for Beigene

Annual Metrics And Ratios for Beigene

Quarterly Metrics And Ratios for Beigene

Frequently Asked Questions About Beigene's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools